Who owns AbbVie Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ABBV from SEC Form 13F filings across 4,261 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 4,261 institutions disclosed 1.32B shares of AbbVie Inc. worth $343.01B — about 74.4% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
4,261
13F holders
$343.01B
value, 2026 filers
74.4%
of shares outstanding (1.32B sh)
233
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ABBV's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 149.0M | $38.97B | 0.6% | 8.4% | -0.3% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 115.7M | $30.26B | 0.6% | 6.5% | +0.2% |
| 3 | STATE STREET CORP | 82.8M | $21.66B | 0.6% | 4.7% | +0.3% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 49.0M | $12.82B | 0.6% | 2.8% | +1.1% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 47.5M | $12.40B | 0.6% | 2.7% | +1.1% |
| 6 | JPMORGAN CHASE & CO | 45.3M | $11.94B | 0.6% | 2.6% | -5.3% |
| 7 | MORGAN STANLEY | 38.4M | $10.04B | 0.5% | 2.2% | -1.3% |
| 8 | Capital Research Global Investors | 31.1M | $8.14B | 1.2% | 1.8% | +3.4% |
| 9 | BANK OF AMERICA CORP /DE/ | 26.4M | $6.90B | 0.4% | 1.5% | +24.2% |
| 10 | Capital World Investors | 20.7M | $5.40B | 0.7% | 1.2% | +7.7% |
| 11 | FMR LLC | 20.2M | $5.28B | 0.2% | 1.1% | -2.8% |
| 12 | NORTHERN TRUST CORP | 19.8M | $5.17B | 0.6% | 1.1% | -3.9% |
| 13 | FRANKLIN TEMPLETON INC | 19.7M | $5.81B | 1.2% | 1.1% | -1.1% |
| 14 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 19.7M | $5.14B | 0.8% | 1.1% | +37.8% |
| 15 | Capital International Investors | 16.2M | $4.23B | 0.9% | 0.9% | +3.4% |
| 16 | Bank of New York Mellon Corp | 15.0M | $3.93B | 0.6% | 0.8% | +16.9% |
| 17 | PRICE T ROWE ASSOCIATES INC /MD/ | 14.8M | $3.86B | 0.4% | 0.8% | +0.1% |
| 18 | GOLDMAN SACHS GROUP INC | 14.4M | $3.76B | 0.3% | 0.8% | -11.8% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13.0M | $3.40B | 0.4% | 0.7% | +0.7% |
| 20 | UBS Group AG | 11.9M | $3.12B | 0.4% | 0.7% | -7.2% |
| 21 | Amundi | 11.7M | $3.07B | 0.6% | 0.7% | +16.7% |
| 22 | Legal & General Group Plc | 11.5M | $3.01B | 0.6% | 0.7% | -0.3% |
| 23 | AMERIPRISE FINANCIAL INC | 11.4M | $2.98B | 0.6% | 0.6% | -1.3% |
| 24 | DEUTSCHE BANK AG\ | 11.1M | $2.91B | 0.8% | 0.6% | +3.3% |
| 25 | WELLINGTON MANAGEMENT GROUP LLP | 10.7M | $2.80B | 0.5% | 0.6% | +111.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.